Proton nuclear magnetic resonance solvent shifts in aqueous electrolyte solutions. II. Mixtures of two salts. Additivity and nonlinearity of shifts

1969 ◽  
Vol 73 (11) ◽  
pp. 3652-3660 ◽  
Author(s):  
John E. Gordon ◽  
Robert L. Thorne
Keyword(s):  
Nuclear Magnetic Resonance ◽  
Magnetic Resonance ◽  
Aqueous Electrolyte ◽  
Electrolyte Solutions ◽  
Proton Nuclear Magnetic Resonance ◽  
Aqueous Electrolyte Solutions ◽  
Solvent Shifts ◽  
Nuclear Magnetic

The Investigation of Cation–Anion Interactions by 39K Nuclear Magnetic Resonance

1972 ◽  
Vol 50 (23) ◽  
pp. 3926-3930 ◽  
Author(s):  
E. G. Bloor ◽  
R. G. Kidd
Keyword(s):  
Nuclear Magnetic Resonance ◽  
Magnetic Resonance ◽  
Aqueous Electrolyte ◽  
Chemical Shifts ◽  
Electrolyte Solutions ◽  
Outer Electron ◽  
Aqueous Electrolyte Solutions ◽  
Nuclear Magnetic

The 39K chemical shifts in a number of aqueous electrolyte solutions have been determined. These arise from the overlapping of the outer electron orbitals of the anion and cation during random ionic collisions. The magnitudes of the chemical shifts are shown to be directly proportional to the effectiveness of this overlap interaction.

scholarly journals N-[7-Chloro-4-[4-(phenoxymethyl)-1H-1,2,3-triazol-1-yl] quinoline]-acetamide

Molbank ◽  
10.3390/m1213 ◽  
2021 ◽  
Vol 2021 (2) ◽  
pp. M1213
Author(s):  
Paolo Coghi ◽  
Jerome P. L. Ng ◽  
Ali Adnan Nasim ◽  
Vincent Kam Wai Wong
Keyword(s):  
Nuclear Magnetic Resonance ◽  
Magnetic Resonance ◽  
Quantum Coherence ◽  
Biologically Active ◽  
Proton Nuclear Magnetic Resonance ◽  
Dipolar Cycloaddition ◽  
Heteronuclear Single Quantum Coherence ◽  
Pharmacokinetic Properties ◽  
Nuclear Magnetic

The 1,2,3-triazole is a well-known biologically active pharmacophore constructed by the copper-catalyzed azide–alkyne cycloaddition. We herein reported the synthesis of 4-amino-7-chloro-based [1,2,3]-triazole hybrids via Cu(I)-catalyzed Huisgen 1,3-dipolar cycloaddition of 4-azido-7-chloroquinoline with an alkyne derivative of acetaminophen. The compound was fully characterized by Fourier-transform infrared (FTIR), proton nuclear magnetic resonance (1H-NMR), carbon-13 nuclear magnetic resonance (13C-NMR), heteronuclear single quantum coherence (HSQC), ultraviolet (UV) and high-resolution mass spectroscopies (HRMS). This compound was screened in vitro with different normal and cancer cell lines. The drug likeness of the compound was also investigated by predicting its pharmacokinetic properties.

Sign in / Sign up

Export Citation Format

Share Document